Retatrutide Dosing by Goal: Titration and Target Doses

Retatrutide is a research compound studied as a triple receptor agonist. It is not approved for human use, so the numbers below describe how doses were stepped up in clinical trials, not a personal protocol. Any real dosing decision belongs with a licensed clinician.

The pattern most people search for under retatrutide dosing schedule is the slow titration used in published trials: start low, hold each step for several weeks, then move up. The point of the ramp is to let the body adjust before reaching a higher target. Below is the general structure, the common target range, and how to turn each milligram step into units on an insulin syringe.

The trial titration pattern

Phase 2 trials escalated retatrutide in roughly 4-week blocks. A representative monthly schedule looked like this:

• Weeks 1-4: 2 mg once weekly
• Weeks 5-8: 4 mg once weekly
• Weeks 9-12: 4 mg or step toward 8 mg
• Weeks 13-16: 8 mg once weekly
• Continue stepping every 4 weeks toward the assigned target (8 mg or 12 mg)

Some trial arms used a gentler entry, starting at 1 mg or 2 mg and doubling slowly so the highest arm reached 12 mg over several months. The shared idea is small jumps held long enough to see how each step is tolerated before the next increase.

Target dose range

The doses studied most often cluster in three target bands once titration is complete:

• Lower target: around 4 mg weekly
• Mid target: around 8 mg weekly
• Upper target: around 12 mg weekly

Higher targets were always reached by climbing through the lower steps first, never started cold. For how researchers map targets to different goals, see the retatrutide dose by goal overview and the retatrutide dosing guide.

Turning each step into units

Vials ship as dry powder, so the milligram step only becomes a measurable volume after reconstitution. Concentration depends on how much bacteriostatic water you add. The formula is the same every time:

Concentration (mg/mL) = peptide mg in vial / mL of water added. Then volume (mL) = dose mg / concentration, and units = volume mL x 100 on a U-100 insulin syringe.

Worked example. A 10 mg vial reconstituted with 1 mL of water gives 10 mg/mL. On that vial:

• 2 mg dose = 0.20 mL = 20 units
• 4 mg dose = 0.40 mL = 40 units
• 8 mg dose = 0.80 mL = 80 units

Same 10 mg vial, but with 2 mL of water, gives 5 mg/mL, so every number doubles in volume:

• 2 mg dose = 0.40 mL = 40 units
• 4 mg dose = 0.80 mL = 80 units
• 8 mg dose = 1.6 mL = 160 units (more than one syringe fill)

The dose in milligrams did not change, only the volume you draw. That is why running each step through the retatrutide calculator matters: it locks the concentration and shows the exact units for every titration step so you are not doing the conversion by hand each week. The general reconstitution calculator handles the same math for any vial size.

Why the steps are spaced out

The 4-week holds are not arbitrary. Spacing gives time at each level before adding more, and it makes the unit math predictable: you reconstitute once, then move from 20 to 40 to 80 units on the same vial as the schedule climbs. If you reconstitute fresh vials at different water volumes along the way, recheck the units each time because the unit count shifts even when the milligram step is identical.

For background on how concentration drives every number here, the peptide vial concentration explained and how to reconstitute retatrutide guides walk through the setup step by step.

Bottom line

The retatrutide schedule studied in trials is a slow climb in roughly 4-week steps toward a target of about 4, 8, or 12 mg weekly, always reached from the bottom up. The milligram steps are fixed, but the units you draw depend entirely on your reconstitution. Set the concentration, run each step through the calculator, and the schedule becomes a simple unit count. None of this is medical guidance; confirm any plan with a qualified clinician. See the disclaimer for more.